Precede Biosciences

Breaking Barriers in Precision Medicine

Boston, United States · Founded 2021 · $63.5M raised

Headquarters
Boston
Employees
11–50
Founded
2021
Business Model
B2B
Total Funding
$63.5M
Last Round
$63.5M Series BJan 2026
Rounds
1

About

Precede Biosciences has developed a first-in-class liquid biopsy platform that profiles circulating chromatin and the DNA methylome from just 1mL of plasma. The platform provides genome-wide insight into gene promoters, enhancers, and methylation patterns to reveal disease-defining transcriptional biology. The company partners with drug developers and academic researchers to accelerate precision-medicine development and create blood-based clinical tests as alternatives to invasive tissue biopsies.

Summary

Precede Biosciences is a Biotech company based in Boston, United States, founded in 2021. It has raised $63.5M in total across 1 round, most recently a $63.5M Series B round in Jan 2026. Investors include Labcorp Venture Fund, UPMC Enterprises and Mirae Asset Capital Life Science.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series BSeries BJan 2026
$63.5M

Sign up to see all 2 rounds

Series B through Debt Financing — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Precede Biosciences on Indexed.vc
<a href="https://indexed.vc/companies/precede-biosciences"><img src="https://indexed.vc/api/badge/company/precede-biosciences" alt="Precede Biosciences on Indexed.vc" width="260" height="76" /></a>